COMMUNIQUÉS West-GlobeNewswire

Teleflex Announces Quarterly Dividend
06/11/2025
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The [...]
Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook
06/11/2025
Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year period Third Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year period Adjusted EBITDA for Q3 [...]
Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
06/11/2025
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 28, 2025. Third quarter financial summary GAAP [...]
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH
06/11/2025
-- Company will host a webcast at 10am ET on November 6, 2025, to discuss its Phase 2a study to assess efficacy, safety and tolerability of BMB-101 (NOVA Study) for the treatment of patients with Prader-Willi Syndrome [...]
4DMT Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
06/11/2025
EMERYVILLE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Enovis Announces Third Quarter 2025 Results
06/11/2025
Diversified growth platform delivers third-quarter sales growth of 9% on a reported basis, 7% organically Third-quarter Reconstructive sales grew 12% year-over-year on a reported basis, 9% organically October [...]
Reviv Celebrates Over 20,000 Customers Worldwide
06/11/2025
A Global Phenomenon in Addressing TMJ Disorder and Related Health Issues Wilmington, DE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Reviv , a pioneering direct-to-consumer wellness brand, proudly announces a significant [...]
4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting 4D-150’s Potential as a Backbone Therapy with Consistent and Durable Benefit over Multiple Years
06/11/2025
4D-150 demonstrated consistent and durable benefit across all three patient cohorts as evidenced by maintenance of visual acuity, control of retinal anatomy and reduction of treatment burden at all time points with up [...]
LifeStance Reports Third Quarter 2025 Results
06/11/2025
SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third [...]
Privia Health Reports Third Quarter 2025 Financial Results
06/11/2025
Very Strong Third Quarter and Year-to-Date Performance Across the Business Net Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q’24 Implemented Providers +13.1% and Practice Collections +27.1% compared to 3Q’24 FY [...]
Novonesis delivered 8% organic sales growth in the first nine months of 2025
06/11/2025
Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards. COPENHAGEN, Denmark – November 6, 2025. Novonesis delivered 8% organic sales growth in the first nine [...]
BlueWillow Biologics’ Intranasal Bird Flu Vaccine Shows Signs of Broad Immune Response in Phase I Clinical Trial Published in Nature Communications
06/11/2025
New study published in Nature Communications paves the way for next-generation pandemic preparedness, demonstrating safety and immunogenicity of adjuvanted intranasal bird flu vaccine ANN ARBOR, Mich., Nov. 06, 2025 ( [...]
arcoris bio raises CHF 6.3 million seed round to advance next-generation biomarker technology for digital pathology
06/11/2025
Schlieren, Switzerland, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Round co-led by Ventura Ace and ZEISS Ventures, with participation from Zürcher Kantonalbank (ZKB) and new as well as existing private investors. MUSE ® , [...]
CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to the large-scale deployment of CARBIOS’ PET biorecycling technology in Asia, with the first step being the construction of a PET biorecycling plant in China.
06/11/2025
The two Groups have reached a binding agreement on the main principles of their collaboration, with a view to deploying a capacity of one million tonnes in the long term, Starting with the construction of a plant in [...]
CARBIOS et Wankai New Materials, filiale du Groupe Zhink, s’engagent pour le déploiement à très grande échelle de la technologie de biorecyclage du PET de CARBIOS en Asie, avec comme première étape la construction d’une usine en Chine.
06/11/2025
Les deux Groupes se sont accordés de manière engageante sur les grands principes de leur collaboration, en vue de déployer une capacité de 1 million de tonnes à long terme, Débutant par la construction en Chine d’une [...]
8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards.
06/11/2025
Ester Baiget, President & CEO: ” I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability and cash flow. Our performance was strong across all [...]
Interim Report Q3 2025: Solid quarter with 1% organic growth, 11% EBITA margin and DKK 410 million cash flow
06/11/2025
Highlights The Hearing division delivered 7% organic revenue growth driven by the continued strong performance of ReSound Vivia, enabling broad-based market share gains. The divisional profit margin ended at 34%, driven [...]
Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow
06/11/2025
Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024 RUCONEST® third quarter revenu e increased by 29% to US$82.2 million, compared to third quarter 2024, reflecting [...]
BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of Bv100 in China
06/11/2025
Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Nov. 06, 2025 (GLOBE NEWSWIRE) -- First healthy volunteer dosed with BV100 in China in mandatory Phase 1 trial Inclusion of Chinese clinical sites by H2 [...]

Pages